↓ Skip to main content

Stimulation of soluble guanylate cyclase by vericiguat reduces skeletal muscle atrophy of mice following chemotherapy

Overview of attention for article published in Frontiers in Pharmacology, January 2023
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
11 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Stimulation of soluble guanylate cyclase by vericiguat reduces skeletal muscle atrophy of mice following chemotherapy
Published in
Frontiers in Pharmacology, January 2023
DOI 10.3389/fphar.2023.1112123
Pubmed ID
Authors

Bo-ang Hu, Yu-lin Li, Hai-tao Han, Bin Lu, Xu Jia, Lu Han, Wei-xuan Ma, Ping Zhu, Zhi-hao Wang, Wei Zhang, Ming Zhong, Lei Zhang

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 11 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 11 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 3 27%
Student > Master 2 18%
Researcher 2 18%
Student > Bachelor 1 9%
Unspecified 1 9%
Other 2 18%
Readers by discipline Count As %
Medicine and Dentistry 3 27%
Pharmacology, Toxicology and Pharmaceutical Science 2 18%
Biochemistry, Genetics and Molecular Biology 2 18%
Nursing and Health Professions 2 18%
Unspecified 1 9%
Other 1 9%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 January 2023.
All research outputs
#18,342,998
of 23,572,442 outputs
Outputs from Frontiers in Pharmacology
#7,531
of 17,169 outputs
Outputs of similar age
#276,825
of 429,538 outputs
Outputs of similar age from Frontiers in Pharmacology
#299
of 917 outputs
Altmetric has tracked 23,572,442 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 17,169 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one is in the 48th percentile – i.e., 48% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 429,538 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 31st percentile – i.e., 31% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 917 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.